We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$92.6M
AUM Growth
+$5.75M
Cap. Flow
+$2.55M
Cap. Flow %
2.76%
Top 10 Hldgs %
32.24%
Holding
102
New
26
Increased
26
Reduced
27
Closed
15
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.58M
2
VTRS icon
Viatris
VTRS
+$3.19M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.28M
4
ELV icon
Elevance Health
ELV
+$1.89M
5
MSFT icon
Microsoft
MSFT
+$1.76M

Top Sells

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$4.96M
2
NOW icon
ServiceNow
NOW
+$1.78M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.34M
4
CI icon
Cigna
CI
+$1.28M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 64.08%
2 Technology 15.15%
3 Miscellaneous 7.32%
4 Communication Services 6.25%
5 Financials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALNA
1
DELISTED
Allena Pharmaceuticals
ALNA
$5.7M 6.15%
575,407
– –
2017 Q4
1 quarter
BMY icon
2
Bristol-Myers Squibb
BMY
$122B
$3.52M 3.81%
+55,719
New +$3.58M
2018 Q1
0 quarters
VTRS icon
3
Viatris
VTRS
$21.4B
$3.08M 3.33%
+74,850
New +$3.19M
2018 Q1
0 quarters
ELV icon
4
Elevance Health
ELV
$92.9B
$3.02M 3.26%
13,753
+8,064
+142% +$1.89M
2016 Q4
5 quarters
BAX icon
5
Baxter International
BAX
$13.1B
$2.81M 3.03%
43,151
+16,104
+60% +$1.09M
2017 Q1
4 quarters
MSFT icon
6
Microsoft
MSFT
$3.93T
$2.51M 2.71%
27,467
+19,198
+232% +$1.76M
2017 Q1
4 quarters
PTLA
7
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.36M 2.55%
72,284
-12,833
-15% -$563K
2016 Q4
5 quarters
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$13.6B
$2.35M 2.53%
+15,538
New +$2.28M
2018 Q1
0 quarters
UNH icon
9
UnitedHealth
UNH
$360B
$2.28M 2.47%
10,667
+2,759
+35% +$630K
2016 Q2
7 quarters
ABT icon
10
Abbott
ABT
$181B
$2.21M 2.39%
36,915
+149
+0.4% +$8.98K
2017 Q2
3 quarters
GDDY icon
11
GoDaddy
GDDY
$13.4B
$2.07M 2.23%
33,638
-16,781
-33% -$949K
2016 Q4
5 quarters
ZBH icon
12
Zimmer Biomet
ZBH
$18.1B
$2.03M 2.19%
19,158
+4,391
+30% +$510K
2017 Q4
1 quarter
AERI
13
DELISTED
Aerie Pharmaceuticals
AERI
$1.98M 2.14%
36,471
+2,783
+8% +$156K
2015 Q1
12 quarters
PBYI icon
14
Puma Biotechnology
PBYI
$507M
$1.85M 2%
27,154
+785
+3% +$58.8K
2016 Q4
5 quarters
HUM icon
15
Humana
HUM
$49.6B
$1.81M 1.96%
6,738
+486
+8% +$132K
2016 Q3
6 quarters
PYPL icon
16
PayPal
PYPL
$48.5B
$1.76M 1.9%
23,143
+5,124
+28% +$406K
2016 Q4
5 quarters
MOH icon
17
Molina Healthcare
MOH
$10.8B
$1.74M 1.88%
21,387
+1,282
+6% +$103K
2016 Q2
7 quarters
DATA
18
DELISTED
Tableau Software, Inc.
DATA
$1.69M 1.82%
+20,886
New +$1.65M
2018 Q1
0 quarters
CRM icon
19
Salesforce
CRM
$198B
$1.67M 1.81%
14,383
-6,956
-33% -$799K
2017 Q2
3 quarters
BMY icon
20
CALL
Bristol-Myers Squibb
BMY
$122B
$1.65M 1.78%
+26,000
New +$1.67M
2018 Q1
0 quarters
EW icon
21
Edwards Lifesciences
EW
$49.9B
$1.63M 1.76%
35,070
-21,810
-38% -$947K
2014 Q4
13 quarters
CME icon
22
CME Group
CME
$106B
$1.49M 1.61%
9,205
-1,025
-10% -$163K
2017 Q4
1 quarter
TWTR
23
DELISTED
Twitter, Inc.
TWTR
$1.42M 1.53%
+48,932
New +$1.43M
2018 Q1
0 quarters
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.17T
$1.4M 1.51%
26,920
+4,980
+23% +$276K
2017 Q2
3 quarters
BIDU icon
25
Baidu
BIDU
$27.3B
$1.33M 1.44%
5,969
-4,084
-41% -$1.01M
2017 Q4
1 quarter
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Partner Investment Management held 102 positions worth $92.6M, up 6.6% from $86.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management's Q1 2018 filing shows 26 new, 26 increased, 27 reduced and 15 closed positions. Its largest new stake was Bristol-Myers Squibb: 55,719 shares worth $3.52M. The largest sale was Sienna Biopharmaceuticals, Inc., an estimated $4.96M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 60% a quarter earlier, followed by Technology and Miscellaneous.

  • Partner Investment Management's largest Q1 2018 buy was Bristol-Myers Squibb: 55,719 shares worth $3.52M.
  • Partner Investment Management added most to Elevance Health in Q1 2018, an estimated $1.89M increase.
  • Partner Investment Management's biggest Q1 2018 reduction was Sienna Biopharmaceuticals, Inc., cutting an estimated $4.96M.
  • Partner Investment Management fully exited ServiceNow in Q1 2018, selling an estimated $1.78M.
  • Partner Investment Management's ten largest holdings make up 32% of its $92.6M portfolio in Q1 2018.
  • Partner Investment Management opened 26 new positions and closed 15 in Q1 2018.
  • Partner Investment Management's portfolio value rose 6.6% quarter-over-quarter to $92.6M.

Based on Partner Investment Management's 13F filing for Q1 2018, filed 15 May 2018.